- Work/Life Balance
- Culture & Values
- Career Opportunities
- Comp & Benefits
- Senior Management
I worked at XDxRecommendsPositive OutlookApproves of CEORecommendsPositive OutlookApproves of CEO
People are very polite and a pleasure to work with.
Some trial data were not posted on the corporate electronic document system, and were, instead, hidden in old emails from former workers or printed out and stored in poorly organized file folders. Statistical details were changed by the FDA and several statistical methods were used, making this a challenging set of documents to write. Consultants were not invited to meetings as much as necessary.
Advice to Management
Consider consultants as employees, so that they can get the job done as well as employees.
Getting an Interview
Getting an Interview
- Accepted OfferPositive ExperienceAverage Interview
I applied through a recruiter. The process took 1 day – interviewed at XDx (Brisbane, CA) in September 2014.
Having had a phone interview with the Real Staffing Hiring Manager, I had a straight-forward 1.5-hour meeting with stake holders who had knowledge about the job in question and had access to my resume. I met with the statistician, then the clinical science liaison, then the EVP/CMO. We discussed common problems working with Key Opinion Leaders, CONSORT rules about trial flow diagrams.
- Why are you interested in contract work? 1 Answer
I gave my current hourly rate to the Real Staffing Hiring Manager, who said it was within the range specified by the company.
Let us know if we're missing any workplace or industry recognition –
Rejection hurts, but organ transplant rejection hurts worse, and XDx wants to help. The company makes tests that monitor for cellular rejection in heart transplants. Its FDA-approved AlloMap test measures gene expression in patients' blood samples to determine if a transplanted heart has been accepted. The company believes its tests will help reduce costs by decreasing the number of biopsies and drug therapies often used in evaluating transplants in patients. XDx also has explored the development of AlloMap for lung transplant patients, and it has other molecular ...